This document provides an overview of topics to be covered in a CCRN review course. It includes objectives related to cardiovascular conditions like acute coronary syndromes, acute myocardial infarction, heart blocks, heart failure, aortic aneurysms, and cardiomyopathy. It also discusses respiratory conditions, shock states, and gastrointestinal alterations. For each topic, it defines key terms, describes signs and symptoms, and outlines standard treatment approaches.
Russian Call Girls in Andheri Airport Mumbai WhatsApp 9167673311 💞 Full Nigh...
CCRN Review part 1
1. ““Never let what you cannot doNever let what you cannot do
interfere with what you can do”interfere with what you can do”
-- John WoodenJohn Wooden --
CCRN REVIEW PART 1CCRN REVIEW PART 1
Sherry L. Knowles, RN, CCRN, CRNISherry L. Knowles, RN, CCRN, CRNI
3.
OBJECTIVESOBJECTIVES
1.1. Understand the different types of acute coronary syndromes.Understand the different types of acute coronary syndromes.
2.2. Identify basic coronary circulation and how it relates to different types ofIdentify basic coronary circulation and how it relates to different types of
myocardial infarctions.myocardial infarctions.
3.3. Anticipate potential complications associated with an AMI.Anticipate potential complications associated with an AMI.
4.4. Identify the standard treatment of an AMI.Identify the standard treatment of an AMI.
5.5. Distinguish between various AV blocks.Distinguish between various AV blocks.
6.6. Recognize the signs & symptoms of heart failure.Recognize the signs & symptoms of heart failure.
7.7. Identify the treatment of heart failure.Identify the treatment of heart failure.
8.8. Recognize the general definition and classifications of aortic aneurysms.Recognize the general definition and classifications of aortic aneurysms.
9.9. Understand the different types of aortic dissections.Understand the different types of aortic dissections.
10.10. Recognize the signs & symptoms of cardiomyopathy.Recognize the signs & symptoms of cardiomyopathy.
11.11. Differentiate between the different types of cardiomyopathy.Differentiate between the different types of cardiomyopathy.
12.12. Identify the treatment for the different types of cardiomyopathy.Identify the treatment for the different types of cardiomyopathy.
13.13. Understand the different stages of shock.Understand the different stages of shock.
14.14. Differentiate between different types of shock.Differentiate between different types of shock.
CCRN REVIEW PART 1CCRN REVIEW PART 1
4.
OBJECTIVESOBJECTIVES
15.15. Distinguish between arterial and venous peripheral vascular disease.Distinguish between arterial and venous peripheral vascular disease.
16.16. Identify the various treatments for peripheral vascular disease.Identify the various treatments for peripheral vascular disease.
17.17. Define respiratory failure.Define respiratory failure.
18.18. Identify the various treatments for acute respiratory failure.Identify the various treatments for acute respiratory failure.
19.19. Recognize the signs & symptoms and causes of various respiratoryRecognize the signs & symptoms and causes of various respiratory
alterations.alterations.
20.20. Identify the standard treatment for various respiratory alterations.Identify the standard treatment for various respiratory alterations.
21.21. Identify the components of cardiac output and stroke volume.Identify the components of cardiac output and stroke volume.
22.22. Recognize the pulmonary artery catheter waveforms.Recognize the pulmonary artery catheter waveforms.
23.23. Recognize the basic treatments used for commonly seen hemodynamicRecognize the basic treatments used for commonly seen hemodynamic
profiles.profiles.
24.24. Explain the common causes of gastrointestinal bleeding.Explain the common causes of gastrointestinal bleeding.
25.25. Describe the most commonly seen treatments for GI bleeding.Describe the most commonly seen treatments for GI bleeding.
26.26. Describe the signs & symptoms of acute pancreatitis and availableDescribe the signs & symptoms of acute pancreatitis and available
treatments.treatments.
CCRN REVIEW PART 1CCRN REVIEW PART 1
6.
DEFINITIONSDEFINITIONS
– Term used to cover a group of symptomsTerm used to cover a group of symptoms
compatible with acute myocardial ischemiacompatible with acute myocardial ischemia
– Acute myocardial ischemia is insufficient bloodAcute myocardial ischemia is insufficient blood
supply to the heart muscle usually resulting fromsupply to the heart muscle usually resulting from
coronary artery diseasecoronary artery disease
Acute Coronary SyndromeAcute Coronary Syndrome
7.
DEFINITIONDEFINITION
– Infarction occurs due to mechanical obstructionInfarction occurs due to mechanical obstruction
of a coronary artery (or branch) caused by aof a coronary artery (or branch) caused by a
thrombus, plaque rupture, coronary spasmthrombus, plaque rupture, coronary spasm
and/or dissection.and/or dissection.
– STEMI vs. NSTEMI (non-STEMI)STEMI vs. NSTEMI (non-STEMI)
Acute Myocardial InfarctionAcute Myocardial Infarction
8.
SIGNS & SYMPTOMSSIGNS & SYMPTOMS
– Complains VaryComplains Vary
May include crushing chest pain (which may or mayMay include crushing chest pain (which may or may
not radiate), back, neck, jaw, teeth and/or epigastricnot radiate), back, neck, jaw, teeth and/or epigastric
pain, SOB, nausea/vomiting and dizzinesspain, SOB, nausea/vomiting and dizziness
– ST elevations on ECGST elevations on ECG
– Elevated cardiac enzymesElevated cardiac enzymes
Acute Myocardial InfarctionAcute Myocardial Infarction
9.
SIGNS & SYMPTOMSSIGNS & SYMPTOMS
↑↑ PAWP,PAWP, ↓↓ CO,CO, ↑↑SVR, dysrhythmias, SSVR, dysrhythmias, S44,,
cardiac failure, cardiogenic shockcardiac failure, cardiogenic shock
– Diaphoresis, pallor, referred painsDiaphoresis, pallor, referred pains
– Diabetics and women often present abnormalDiabetics and women often present abnormal
symptomssymptoms
Acute Myocardial InfarctionAcute Myocardial Infarction
11. II AVRAVR V1V1
V4V4
IIII AVL V2 V5AVL V2 V5
IIIIII AVF V3 V6AVF V3 V6
IIII
VV
12 Lead ECG12 Lead ECG
12.
ST ELEVATIONSST ELEVATIONS
– Anterior Wall MIAnterior Wall MI
Leads VLeads V11-V-V44
Reciprocal changes in leads II, III, and aVFReciprocal changes in leads II, III, and aVF
Area supplied by the LADArea supplied by the LAD
– Inferior Wall MIInferior Wall MI
Leads II, III and aVFLeads II, III and aVF
Reciprocal changes in leads I, and aVLReciprocal changes in leads I, and aVL
Area usually supplied by the RCAArea usually supplied by the RCA
Acute Myocardial InfarctionAcute Myocardial Infarction
13. ST ELEVATIONSST ELEVATIONS
– Lateral Wall MILateral Wall MI
I, aVL, VI, aVL, V55 and Vand V66
Area supplied by the Circumflex arteryArea supplied by the Circumflex artery
– Posterior Wall MIPosterior Wall MI
Reflected on the opposite wallsReflected on the opposite walls
Opposite deflectionsOpposite deflections
Acute Myocardial InfarctionAcute Myocardial Infarction
18.
NURSING INTERVENTIONSNURSING INTERVENTIONS
– OO22
– BedrestBedrest
– Serial ECG’sSerial ECG’s
– Serial cardiac enzymesSerial cardiac enzymes
– Keep pain free (NTG. MSOKeep pain free (NTG. MSO44))
– MONAMONA (Morphine, O2, Nitroglycerin, Aspirin),(Morphine, O2, Nitroglycerin, Aspirin),
Heparin, beta-blockers, and ace inhibitors. May alsoHeparin, beta-blockers, and ace inhibitors. May also
include thrombolytics or Gp2b3a inhibitorsinclude thrombolytics or Gp2b3a inhibitors
– PCI, PTCA, IABP, CABGPCI, PTCA, IABP, CABG
Acute Myocardial InfarctionAcute Myocardial Infarction
19.
TREATMENTTREATMENT
– Time Is Heart MuscleTime Is Heart Muscle
– Prompt ECGPrompt ECG
– Goals: Relieve pain, limit the size of theGoals: Relieve pain, limit the size of the
infarction and to prevent complicationsinfarction and to prevent complications
(primarily lethal dysrhythmias)(primarily lethal dysrhythmias)
Acute Myocardial InfarctionAcute Myocardial Infarction
20.
TREATMENTTREATMENT
– MONAMONA (Morphine, O2, Nitroglycerin, Aspirin)(Morphine, O2, Nitroglycerin, Aspirin),,
Heparin, beta-blockers, and ace inhibitors.Heparin, beta-blockers, and ace inhibitors.
May also include thrombolytics or Gp2b3aMay also include thrombolytics or Gp2b3a
inhibitorsinhibitors
– Cardiac Catheterization (with angioplasty,Cardiac Catheterization (with angioplasty,
atherectomy and/or stent)atherectomy and/or stent)
– IABP, CABG, EducationIABP, CABG, Education
Acute Myocardial InfarctionAcute Myocardial Infarction
25. Aortic AneurysmsAortic Aneurysms
DEFINITIONDEFINITION
– A bulge or ballooning of the aortaA bulge or ballooning of the aorta
When the walls of the aneurysm include all threeWhen the walls of the aneurysm include all three
layers of the artery, they are called true aneurysmslayers of the artery, they are called true aneurysms
When the wall of the aneurysm include only theWhen the wall of the aneurysm include only the
outer layer, it is called a pseudo-aneurysmouter layer, it is called a pseudo-aneurysm
– May be thoracic or abdominalMay be thoracic or abdominal
27. Aortic Aneurysms RuptureAortic Aneurysms Rupture
An aortic aneurysm, depending on its size, mayAn aortic aneurysm, depending on its size, may
rupture, causing life-threatening internal bleedingrupture, causing life-threatening internal bleeding
The risk of an aneurysm rupturing increases as theThe risk of an aneurysm rupturing increases as the
aneurysm gets largeraneurysm gets larger
The risk of rupture also depends on the location ofThe risk of rupture also depends on the location of
the aneurysmthe aneurysm
Each year, approximately 15,000 Americans die of aEach year, approximately 15,000 Americans die of a
ruptured aortic aneurysm.ruptured aortic aneurysm.
28. Aortic AneurysmsAortic Aneurysms
CLASSIFICATIONSCLASSIFICATIONS
– Classified by shape, location along the aorta,Classified by shape, location along the aorta,
and how they are formedand how they are formed
– May be symmetrical in shape (fusiform) or aMay be symmetrical in shape (fusiform) or a
localized weakness of the arterial wall (saccular)localized weakness of the arterial wall (saccular)
30. Aortic AneurysmsAortic Aneurysms
SIGNS & SYMPTOMSSIGNS & SYMPTOMS
– Often produces no symptomsOften produces no symptoms
– If an aortic aneurysm suddenly ruptures it presentsIf an aortic aneurysm suddenly ruptures it presents
with extreme abdominal or back pain, a pulsatingwith extreme abdominal or back pain, a pulsating
mass in the abdomen, and a drastic drop in bloodmass in the abdomen, and a drastic drop in blood
pressurepressure
– An increase in the size of an aneurysm means anAn increase in the size of an aneurysm means an
increased in the risk of ruptureincreased in the risk of rupture
31. Aortic AneurysmsAortic Aneurysms
THORACIC SIGNS & SYMPTOMSTHORACIC SIGNS & SYMPTOMS
– Back, shoulder or neck painBack, shoulder or neck pain
– Cough, due to pressure placed on the tracheaCough, due to pressure placed on the trachea
– HoarsenessHoarseness
– Strider, dyspneaStrider, dyspnea
– Difficulty swallowingDifficulty swallowing
– Swelling in the neck or armsSwelling in the neck or arms
32. Aortic DissectionsAortic Dissections
DEFINITIONDEFINITION
– Tearing of the inner layer of the aortic wall, whichTearing of the inner layer of the aortic wall, which
allows blood to leak into the wall itself and causesallows blood to leak into the wall itself and causes
the separation of the inner and outer layersthe separation of the inner and outer layers
– Usually associated with severe chest pain radiatingUsually associated with severe chest pain radiating
to the backto the back
33. Aortic DissectionsAortic Dissections
A.A. DissectionDissection
beginning in thebeginning in the
ascending aortaascending aorta
B.B. Whenever theWhenever the
ascending aortaascending aorta
is not involvedis not involved
34. Aortic DissectionsAortic Dissections
A.A. DissectionDissection
beginning in thebeginning in the
ascending aortaascending aorta
B.B. Whenever theWhenever the
ascending aortaascending aorta
is not involvedis not involved
38. Aortic AneurysmsAortic Aneurysms
TREATMENTTREATMENT
Medical managementMedical management
– Controlled BP (within specific range)Controlled BP (within specific range)
Surgical repairSurgical repair
> 4.5 cm in Marfan patients or > 5 cm in non-> 4.5 cm in Marfan patients or > 5 cm in non-
Marfan patients will require surgicalMarfan patients will require surgical
correction or endovascular stent placementcorrection or endovascular stent placement
40. CardiomyopathyCardiomyopathy
CLASSIFICATIONSCLASSIFICATIONS
– Primary / Idiopathic (intrinsicPrimary / Idiopathic (intrinsic))
Heart disease of unknown cause, although viralHeart disease of unknown cause, although viral
infection and autoimmunity are suspected causesinfection and autoimmunity are suspected causes
– Secondary (extrinsicSecondary (extrinsic))
Heart disease as a result of other systemic diseases,Heart disease as a result of other systemic diseases,
such as autoimmune diseases, CAD, valvularsuch as autoimmune diseases, CAD, valvular
disease, severe hypertension, or alcohol abusedisease, severe hypertension, or alcohol abuse
42. Hypertropic CardiomyopathyHypertropic Cardiomyopathy
Bizarre hypertrophy of the septumBizarre hypertrophy of the septum
– Previously called IHSSPreviously called IHSS
Idiopathic Hypertropic Subaortic StenosisIdiopathic Hypertropic Subaortic Stenosis
– Known as HOCMKnown as HOCM
Hypertropic Obstructive CardiomyopathyHypertropic Obstructive Cardiomyopathy
Positive inotropic drugs ShouldPositive inotropic drugs Should NotNot Be UsedBe Used
↑↑ Contractility willContractility will ↑↑ outflow tract obstructionoutflow tract obstruction
Nitroglycerin ShouldNitroglycerin Should NotNot Be UsedBe Used
– Dilation Will Worsen The ProblemDilation Will Worsen The Problem
44. Hypertropic CardiomyopathyHypertropic Cardiomyopathy
TREATMENTTREATMENT
– Relax the ventriclesRelax the ventricles
Beta BlockersBeta Blockers
Calcium Channel BlockersCalcium Channel Blockers
– Slow the Heart RateSlow the Heart Rate
Increase filling timeIncrease filling time
– Use Negative InotropesUse Negative Inotropes
Optimize diastolic fillingOptimize diastolic filling
– Do Not use NTGDo Not use NTG
Dilation will worsen the problemDilation will worsen the problem
45. Restrictive CardiomyopathyRestrictive Cardiomyopathy
Rigid Ventricular WallRigid Ventricular Wall
– Due to endomyocardial fibrosisDue to endomyocardial fibrosis
– Obstructs ventricular fillingObstructs ventricular filling
Least common formLeast common form
47. Dilated CardiomyopathyDilated Cardiomyopathy
Grossly dilated ventricles without hypertrophyGrossly dilated ventricles without hypertrophy
– Global left ventricular dysfunctionGlobal left ventricular dysfunction
– Leads to pooling of blood and embolic episodesLeads to pooling of blood and embolic episodes
– Leads to refractory heart failureLeads to refractory heart failure
– Leads to papillary muscle dysfunction secondary toLeads to papillary muscle dysfunction secondary to
LV dilationLV dilation
52. Conduction DefectsConduction Defects
STABLE VS UNSTABLESTABLE VS UNSTABLE
– StableStable
Start with medicationsStart with medications
– UnstableUnstable
Shock (cardioversion or defibrillation)Shock (cardioversion or defibrillation)
53. Normal Sinus RhythmNormal Sinus Rhythm
Heart RateHeart Rate 60 - 100 bpm60 - 100 bpm
RhythmRhythm RegularRegular
P WaveP Wave Before each QRS & identicalBefore each QRS & identical
PR Interval (in seconds)PR Interval (in seconds) 0.12 to 0.200.12 to 0.20
QRS (in seconds)QRS (in seconds) < 0.12< 0.12
54. Atrial FibrillationAtrial Fibrillation
AFibAFib
– Multifocal atrial impulses at rate 300-600/minMultifocal atrial impulses at rate 300-600/min
– Irregular conduction to ventriclesIrregular conduction to ventricles
55. Atrial FlutterAtrial Flutter
AFLAFL
– Atrial impulses at rate of 250-350/minAtrial impulses at rate of 250-350/min
– Regularly blocked impulses at the AV nodeRegularly blocked impulses at the AV node
– Saw tooth flutter wavesSaw tooth flutter waves
56. Wandering Atrial PacemakerWandering Atrial Pacemaker
WAPWAP
– Multiple ectopic foci in the atriaMultiple ectopic foci in the atria
– Three or more p wave morphologiesThree or more p wave morphologies
– Rate < 100Rate < 100
57. Supraventricular TachycardiaSupraventricular Tachycardia
SVTSVT
– Supraventricular rhythm at rate 150-250Supraventricular rhythm at rate 150-250
– P waves cannot be positively identifiedP waves cannot be positively identified
Atrial Tach = supraventricular rhythm with p wave morphologyAtrial Tach = supraventricular rhythm with p wave morphology
that is noticeably different from the sinus p wavethat is noticeably different from the sinus p wave
59. Torsades de PointesTorsades de Pointes
Polymorphic VTPolymorphic VT
– VT with alternating ventricular focusVT with alternating ventricular focus
– Often associated with prolonged QT Rate < 100Often associated with prolonged QT Rate < 100
60. Heart Blocks (AV Blocks)Heart Blocks (AV Blocks)
Sinus Rhythm with First Degree AV BlockSinus Rhythm with First Degree AV Block
Sinus Rhythm with Second Degree AV Block, Type 2Sinus Rhythm with Second Degree AV Block, Type 2
Sinus Rhythm with Second Degree AV Block, Type 1Sinus Rhythm with Second Degree AV Block, Type 1
Third Degree AV BlockThird Degree AV Block
61. DEFINITIONDEFINITION
– A condition in which the heart cannot pumpA condition in which the heart cannot pump
sufficient blood to meet the metabolic needs ofsufficient blood to meet the metabolic needs of
the bodythe body
– Pulmonary (LVF) and/or systemic (RVF)Pulmonary (LVF) and/or systemic (RVF)
congestion is present.congestion is present.
Heart FailureHeart Failure
62.
DEFINITIONDEFINITION
– Pulmonary EdemaPulmonary Edema
Fluid in the alveolus that impairs gas exchange byFluid in the alveolus that impairs gas exchange by
altering the diffusion between alveolus andaltering the diffusion between alveolus and capillarycapillary
Acute left ventricular failure causes cardiogenicAcute left ventricular failure causes cardiogenic
pulmonary edemapulmonary edema
Non-cardiogenic pulmonary edema is a synonym forNon-cardiogenic pulmonary edema is a synonym for
Adult Respiratory Distress Syndrome (ARDS)Adult Respiratory Distress Syndrome (ARDS)
Heart FailureHeart Failure
63.
COMPENSATORY MECHANISMSCOMPENSATORY MECHANISMS
– Sympaththetic nervous system stimulationSympaththetic nervous system stimulation
TachycardiaTachycardia
Vasoconstriction and increased SVRVasoconstriction and increased SVR
– Renin-angiotensin-aldosterone systemRenin-angiotensin-aldosterone system
activation (RAAS)activation (RAAS)
Hypo perfusion to the kidneys (renin)Hypo perfusion to the kidneys (renin)
Vasoconstriction (angiotensin)Vasoconstriction (angiotensin)
Sodium and water retention (kidneys)Sodium and water retention (kidneys)
Ventricular dilationVentricular dilation
Heart FailureHeart Failure
64.
FUNCTIONAL CLASSIFICATIONSFUNCTIONAL CLASSIFICATIONS
– Class IClass I
– Class IIClass II
– Class IIIClass III
– Class IVClass IV
Heart FailureHeart Failure
(without noticeable limitations)(without noticeable limitations)
(symptoms upon activity)(symptoms upon activity)
(severe symptoms upon activity)(severe symptoms upon activity)
(symptoms at rest)(symptoms at rest)
68. Peripheral Vascular DiseasePeripheral Vascular Disease
SYMPTOMSSYMPTOMS
PAINPAIN
PAIN RELIEFPAIN RELIEF
EDEMAEDEMA
PULSESPULSES
INTEGUMENTINTEGUMENT
CHANGESCHANGES
ULCERSULCERS
SKIN TEMPERATURESKIN TEMPERATURE
SEXUAL ISSUESSEXUAL ISSUES
ARTERIALARTERIAL
Upon walkingUpon walking
On resting, standing orOn resting, standing or
dependent position of lower limbsdependent position of lower limbs
NoneNone
Decreased or absentDecreased or absent
Hair lossHair loss
Skin shinySkin shiny
Nail thickeningNail thickening
Pallor when elevatedPallor when elevated
Red when dependentRed when dependent
Ulcers located on toes, lateralUlcers located on toes, lateral
areas or site of traumaareas or site of trauma
Gangrene possibleGangrene possible
CoolCool
ImpotencyImpotency
Sexual dysfunctionSexual dysfunction
VENOUSVENOUS
While standingWhile standing
Elevation of extremitiesElevation of extremities
Present, edematousPresent, edematous
May be difficult to palpateMay be difficult to palpate
Brownish pigmentationBrownish pigmentation
May be cyanotic whenMay be cyanotic when
extremities are dependentextremities are dependent
Ulcers located on ankles,Ulcers located on ankles,
medial or pre-tibial areasmedial or pre-tibial areas
Normal or warmNormal or warm
Not presentNot present
71. DEFINITIONDEFINITION
– Inadequate perfusion to the body tissuesInadequate perfusion to the body tissues
– Low blood pressure with impaired perfusionLow blood pressure with impaired perfusion
to the end organsto the end organs
– May result in multiple organ dysfunctionMay result in multiple organ dysfunction
ShockShock
73. ShockShock
COMPENSATORY MECHANISMSCOMPENSATORY MECHANISMS
–TachycardiaTachycardia
Attempts to deliver more blood to the tissuesAttempts to deliver more blood to the tissues
–VasoconstrictionVasoconstriction
Attempts to maintain adequate BP in order toAttempts to maintain adequate BP in order to
adequately perfuse the body tissuesadequately perfuse the body tissues
–Increased ADH SecretionIncreased ADH Secretion
ADH makes the body hold onto water in an effort toADH makes the body hold onto water in an effort to
maintain volume and thus enough blood pressure tomaintain volume and thus enough blood pressure to
perfuse the body tissuesperfuse the body tissues
74. Types of ShockTypes of Shock
Hypovolemic ShockHypovolemic Shock
– Inadequate perfusion to the tissues due to insufficient intravascularInadequate perfusion to the tissues due to insufficient intravascular
volumevolume
Cardiogenic ShockCardiogenic Shock
– Inadequate perfusion to the tissues due to heart failureInadequate perfusion to the tissues due to heart failure
Distributive ShockDistributive Shock
– Inadequate perfusion to the tissues due to blood flow out of theInadequate perfusion to the tissues due to blood flow out of the
intravascular space causing insufficient intravascular volumeintravascular space causing insufficient intravascular volume
– Anaphylactic, Septic, and Spinal ShockAnaphylactic, Septic, and Spinal Shock
Obstructive ShockObstructive Shock
– Inadequate perfusion to the tissues due to obstruction of blood flowInadequate perfusion to the tissues due to obstruction of blood flow
83.
Cardiogenic Shock is the only shock withCardiogenic Shock is the only shock with PAWPPAWP
Early (Hyperdynamic) Shock is the only shock withEarly (Hyperdynamic) Shock is the only shock with CO andCO and
SVRSVR
Neurogenic Shock is the only shock withNeurogenic Shock is the only shock with BradycardiaBradycardia
Anaphylactic Shock has the definitive characteristic of wheezing dueAnaphylactic Shock has the definitive characteristic of wheezing due
to bronchospasmto bronchospasm
Parameter Hypovolemic Cardiogenic Neurogenic Anaphylactic Early Septic Late Septic
CVP/RAP
PAWP or Norm
CO
BP
SVR
HR Normal
Shock ProfilesShock Profiles
84. SIRS Sepsis Severe Septic MODS DeathSIRS Sepsis Severe Septic MODS Death
InfectionInfection Sepsis ShockSepsis Shock
Sepsis SyndromeSepsis Syndrome
85. Sepsis
– SIRS’ response with presumed/confirmed infectionSIRS’ response with presumed/confirmed infection
Severe Sepsis
– Sepsis associated with organ dysfunction, hypoperfusionSepsis associated with organ dysfunction, hypoperfusion
(lactic acidosis, oliguria, altered mental status etc.), or(lactic acidosis, oliguria, altered mental status etc.), or
hypotension (SBP < 90 mmHg or ↓ SBP > 40 mmHg)hypotension (SBP < 90 mmHg or ↓ SBP > 40 mmHg)
Septic Shock
– Sepsis with perfusion abnormalities and hypotensionSepsis with perfusion abnormalities and hypotension
despite adequate fluid resuscitationdespite adequate fluid resuscitation
Sepsis SyndromeSepsis Syndrome
86.
EARLY STAGE (Hyperdynamic)EARLY STAGE (Hyperdynamic)
Normal BPNormal BP TachycardiaTachycardia
ConfusionConfusion Agitation (or listless)Agitation (or listless)
↑↑ Respiratory RateRespiratory Rate TemperatureTemperature
Normal ColorNormal Color Normal orNormal or ↑↑ UOPUOP
Normal PAWPNormal PAWP ↑↑ COCO ↓↓ SVRSVR
LATE STAGE (Hypodynamic)LATE STAGE (Hypodynamic)
Low BPLow BP TachycardiaTachycardia
Orthostatic HypotensionOrthostatic Hypotension RestlessnessRestlessness
ConfusionConfusion Agitation (or listless)Agitation (or listless)
ThirstThirst PallorPallor
Cool, Clammy SkinCool, Clammy Skin ↓↓ UOPUOP
↓↓ COCO ↓↓ PAWPPAWP
↓↓ CVPCVP ↑↑ SVRSVR
↑↑ Lactate LevelsLactate Levels
Septic ShockSeptic Shock
88. 3.3. Improve PerfusionImprove Perfusion
– Prevent organ dysfunctionPrevent organ dysfunction
– Treat temp as neededTreat temp as needed
2.2. Treat The CauseTreat The Cause
– Pan culture, antibioticsPan culture, antibiotics
– Seek primary site of infectionSeek primary site of infection
– Direct therapy to primary causeDirect therapy to primary cause
1.1. Stabilize The PatientStabilize The Patient
– Fluids (lots of fluids) 150ml/hr or moreFluids (lots of fluids) 150ml/hr or more
– VasoconstrictorsVasoconstrictors
Treatment for SepsisTreatment for Sepsis
90. Invasive PA CatheterInvasive PA Catheter
CONTRAINDICATIONSCONTRAINDICATIONS
Mechanical Tricuspid or Pulmonary ValveMechanical Tricuspid or Pulmonary Valve
Right Heart Mass (thrombus and/or tumor)Right Heart Mass (thrombus and/or tumor)
Tricuspid or Pulmonary Valve EndocarditisTricuspid or Pulmonary Valve Endocarditis
91. BasicBasic ConceptsConcepts
CO = HR X SVCO = HR X SV
BP = CO x SVRBP = CO x SVR
CO and SVR are inversely relatedCO and SVR are inversely related
CO and SVR will change before BP changesCO and SVR will change before BP changes
92. StrokeStroke VolumeVolume
Components Stroke VolumeComponents Stroke Volume
– PreloadPreload:: the volume of blood in the ventriclesthe volume of blood in the ventricles
at end diastole and the stretch placed on theat end diastole and the stretch placed on the
muscle fibersmuscle fibers
– AfterloadAfterload:: the resistance the ventricles mustthe resistance the ventricles must
overcome to eject it’s volume of bloodovercome to eject it’s volume of blood
– Contractility:Contractility: the force with which the heartthe force with which the heart
muscle contracts (myocardial compliance)muscle contracts (myocardial compliance)
96. Normal Hemodynamic ValuesNormal Hemodynamic Values
Values normalized for body size (BSA)Values normalized for body size (BSA)
CI:CI: 2.5 – 4.5 L/min/m2.5 – 4.5 L/min/m22
SVRI:SVRI: 1970 – 2390 dynes/sec/cm-5/m21970 – 2390 dynes/sec/cm-5/m2
SVI or SI:SVI or SI: 35 – 60 mL/beat/m235 – 60 mL/beat/m2
EDVI:EDVI: 60 – 100 mL/m260 – 100 mL/m2
97. Mixed Venous Oxygen SaturationMixed Venous Oxygen Saturation
SvO2SvO2
End result of O2 delivery andEnd result of O2 delivery and
consumptionconsumption
Measured in the pulmonary arteryMeasured in the pulmonary artery
An average estimate of venous saturation forAn average estimate of venous saturation for
the whole body.the whole body.
Does not reflect separate tissue perfusion orDoes not reflect separate tissue perfusion or
oxygenationoxygenation
99. Measuring PA PressuresMeasuring PA Pressures
Measure All Hemodynamic ValuesMeasure All Hemodynamic Values
at End-Expirationat End-Expiration
– ““Patient PeakPatient Peak””
– ““Vent ValleyVent Valley””
101.
Measure all pressures atMeasure all pressures at end-expirationend-expiration
AtAt top curvetop curve with Spontaneous Respirationwith Spontaneous Respiration
““patient-peak”patient-peak”
Intrathoracic pressureIntrathoracic pressure decreasesdecreases duringduring
spontaneous inspirationspontaneous inspiration
– Negative deflection on waveformsNegative deflection on waveforms
Intrathoracic pressureIntrathoracic pressure increasesincreases duringduring
spontaneous expirationspontaneous expiration
– Positive deflection on waveformsPositive deflection on waveforms
Measuring PA PressuresMeasuring PA Pressures
102.
Measure all pressures atMeasure all pressures at end-expirationend-expiration
AtAt bottom curvebottom curve with mechanical ventilatorwith mechanical ventilator
““Vent-Valley”Vent-Valley”
Intrathoracic pressureIntrathoracic pressure increasesincreases duringduring
positive pressure ventilations (inspiration)positive pressure ventilations (inspiration)
– Positive deflection on waveformsPositive deflection on waveforms
Intrathoracic pressureIntrathoracic pressure decreasesdecreases duringduring
positive pressure expirationpositive pressure expiration
– Negative deflection on waveformsNegative deflection on waveforms
Measuring PA PressuresMeasuring PA Pressures
103.
104.
105. a-wavea-wave
– Atrial contractionAtrial contraction
– Correct location for measurement of PAWPCorrect location for measurement of PAWP
Average the peak & trough of the a-waveAverage the peak & trough of the a-wave
– Begins near the end of QRS or at the QTBegins near the end of QRS or at the QT
segmentsegment
Delayed ECG correlation from CVP sinceDelayed ECG correlation from CVP since
PA catheter is further away from left atriumPA catheter is further away from left atrium
PAWP WaveformPAWP Waveform
106.
c-wavec-wave
– Rarely presentRarely present
– Represents mitral valve closureRepresents mitral valve closure
v-wavev-wave
– Represents left atrial fillingRepresents left atrial filling
– Begins at about the end of the T waveBegins at about the end of the T wave
PAWP WaveformPAWP Waveform
110. ARDSARDS
DEFINITIONSDEFINITIONS
– Severe respiratory failure associated with pulmonarySevere respiratory failure associated with pulmonary
infiltrates (similar to infant hyaline membrane disease)infiltrates (similar to infant hyaline membrane disease)
– Pulmonary edema in the absence of fluid overload orPulmonary edema in the absence of fluid overload or
depressed LV function (Non-cardiogenic pulmonary edema)depressed LV function (Non-cardiogenic pulmonary edema)
– Originates from a number of insults involving damage to theOriginates from a number of insults involving damage to the
alveolar-capillary membranealveolar-capillary membrane
112. ARDSARDS
PATHOPHYSIOLOGYPATHOPHYSIOLOGY
– Inflammatory mediators are released causing extensiveInflammatory mediators are released causing extensive
structural damagestructural damage
– Increased permeability of pulmonary microvasculatureIncreased permeability of pulmonary microvasculature
causes leakage of proteinaceous fluid across the alveolar–causes leakage of proteinaceous fluid across the alveolar–
capillary membranecapillary membrane
– Also causes damage to the surfactant-producing type II cellsAlso causes damage to the surfactant-producing type II cells
113. ARDSARDS
CXR CHARACTERISTICSCXR CHARACTERISTICS
– Normal size heartNormal size heart
– No pleural effusionNo pleural effusion
– Ground GlassGround Glass appearanceappearance
– Often normal early in the disease but may rapidlyOften normal early in the disease but may rapidly
progress to complete whiteoutprogress to complete whiteout
115. ARDSARDS
SIGNS & SYMPTOMSSIGNS & SYMPTOMS
– Symptoms develop 24 to 48 hours of injurySymptoms develop 24 to 48 hours of injury
Sudden progressive disorderSudden progressive disorder
Pulmonary edemaPulmonary edema
Severe dyspneaSevere dyspnea
HypoxemiaHypoxemia REFRACTORYREFRACTORY to O2to O2
Decreased lung complianceDecreased lung compliance
Diffuse pulmonary infiltratesDiffuse pulmonary infiltrates
– Symptoms may be minimal compared to CXRSymptoms may be minimal compared to CXR
– Rales may be heardRales may be heard
118. Chronic Lung DiseaseChronic Lung Disease
COPDCOPD
– Presents with hyper-inflated lung fieldsPresents with hyper-inflated lung fields
Due to chronic air trappingDue to chronic air trapping
May be barrel chestedMay be barrel chested
– May lead to cor pulmonaleMay lead to cor pulmonale (right-sided heart failure)(right-sided heart failure)
Due to chronic high pulmonary pressuresDue to chronic high pulmonary pressures
– Often hypercarbic (high pCO2)Often hypercarbic (high pCO2)
Often dependent upon hypoxic driveOften dependent upon hypoxic drive
120. Near DrowningNear Drowning
Salt WaterSalt Water
– Causes body fluids to shift into lungsCauses body fluids to shift into lungs
Osmosis: From low to high concentrationOsmosis: From low to high concentration
Results in hemoconcentration & hypovolemiaResults in hemoconcentration & hypovolemia
– Results in acute pulmonary edemaResults in acute pulmonary edema
Fresh WaterFresh Water
– Fluids shift into body tissuesFluids shift into body tissues
Results in hemodilution & hypervolemiaResults in hemodilution & hypervolemia
Can result in gross edemaCan result in gross edema
– Damaged alveoli fill with proteinaceous fluidDamaged alveoli fill with proteinaceous fluid
May lead to pulmonary edemaMay lead to pulmonary edema
121. PneumoniaPneumonia
Lung infection (bacterial, viral, or fungal)Lung infection (bacterial, viral, or fungal)
– Most commonly caused by SMost commonly caused by Streptococcustreptococcus
pneumoniaepneumoniae
Symptoms include fever, pleuretic chestSymptoms include fever, pleuretic chest
pain, productive cough, and tachypneapain, productive cough, and tachypnea
– Often presents bronchial breath sounds over theOften presents bronchial breath sounds over the
lung arealung area
Treatment involves giving the right antibioticTreatment involves giving the right antibiotic
122. PneumothoraxPneumothorax
DEFINITIONSDEFINITIONS
– Simple pneumothoraxSimple pneumothorax
Results from buildup of air or pressure in the pleural spaceResults from buildup of air or pressure in the pleural space
– Spontaneous pneumothoraxSpontaneous pneumothorax
May be due to blebs that ruptureMay be due to blebs that rupture
The 2 key risk factors are increased chest length andThe 2 key risk factors are increased chest length and
cigarette smokingcigarette smoking
– Tension pneumothoraxTension pneumothorax
Involves a buildup of air in the pleural space due toInvolves a buildup of air in the pleural space due to
one-way movement of airone-way movement of air
Progressively worsensProgressively worsens
Requires immediate interventionRequires immediate intervention
126. PneumothoraxPneumothorax
SIGNS & SYMPTOMSSIGNS & SYMPTOMS
– Standard PneumothoraxStandard Pneumothorax
Sharp "pleuritic" chest pain, worse on breathingSharp "pleuritic" chest pain, worse on breathing
Sudden shortness of breathSudden shortness of breath
Dry, hacking cough (may occur due to irritationDry, hacking cough (may occur due to irritation
of the diaphragm)of the diaphragm)
May cause mediastinal shiftMay cause mediastinal shift
– Tension pneumothoraxTension pneumothorax
Signs of standard pneumothorax with signs ofSigns of standard pneumothorax with signs of
cardiovascular collapsecardiovascular collapse
Immediately life threateningImmediately life threatening
May cause mediastinal shiftMay cause mediastinal shift
127. PneumothoraxPneumothorax
TREATMENTTREATMENT
Spontaneous pneumothoraxSpontaneous pneumothorax
– Depends on symptoms & size of pneumothoraxDepends on symptoms & size of pneumothorax
– Provide respiratory supportProvide respiratory support
– May need chest tube or needle decompressionMay need chest tube or needle decompression
Some resolve without interventionSome resolve without intervention
Tension pneumothoraxTension pneumothorax
– RequiresRequires immediateimmediate interventionintervention
– May cause cardiovascular collapseMay cause cardiovascular collapse
– May need chest tube or needle decompressionMay need chest tube or needle decompression
22ndnd
intercostal spaceintercostal space
130. DefinitionDefinition
Signs & SymptomsSigns & Symptoms
Pulmonary EmbolismPulmonary Embolism
– Arterial embolus that obstructs blood flow to the lungArterial embolus that obstructs blood flow to the lung
– Symptoms include sudden dyspnea, cough, chestSymptoms include sudden dyspnea, cough, chest
pain, hemoptysis and sinus tachycardiapain, hemoptysis and sinus tachycardia
– Blood gas shows low pO2 & low pCO2Blood gas shows low pO2 & low pCO2
– May present positive Homan’s SignMay present positive Homan’s Sign
– May present loud S2May present loud S2
131.
Diagnostic TestsDiagnostic Tests
– CXRCXR
– VQ ScanVQ Scan
– Spiral CTSpiral CT
– Pulmonary arteriogram/angiogramPulmonary arteriogram/angiogram
– Venous ultrasound of the lower extremitiesVenous ultrasound of the lower extremities
– ABG with low pO2 & low pCO2ABG with low pO2 & low pCO2
– D-DimerD-Dimer
Pulmonary EmbolismPulmonary Embolism
132.
TreatmentTreatment
– Requires immediate interventionRequires immediate intervention
– Provide respiratory supportProvide respiratory support
– Treat pain & comfortTreat pain & comfort
– Usually includes intravenous heparinUsually includes intravenous heparin
Heparin reduces risk of secondaryHeparin reduces risk of secondary
thrombus formation while clot is reabsorbedthrombus formation while clot is reabsorbed
– May require embolectomyMay require embolectomy
– May require thrombolysisMay require thrombolysis
– May need umbrella filterMay need umbrella filter
– May need long term anticoagulantsMay need long term anticoagulants
Pulmonary EmbolismPulmonary Embolism
133. Respiratory FailureRespiratory Failure
DEFINITIONSDEFINITIONS
– Failure to maintain adequate gas exchangeFailure to maintain adequate gas exchange
– Inadequate blood oxygenation or CO2 removalInadequate blood oxygenation or CO2 removal
– PaO2 < 50 mmHg and/or PaCO2 > 50 mmHgPaO2 < 50 mmHg and/or PaCO2 > 50 mmHg
and/or pH < 7.35and/or pH < 7.35 on Room Airon Room Air
134. Respiratory FailureRespiratory Failure
TYPE ITYPE I HypoxemiaHypoxemia withoutwithout hypercapniahypercapnia
TYPE IITYPE II HypoxemiaHypoxemia withwith hypercapniahypercapnia
140. Respiratory FailureRespiratory Failure
TREATMENTTREATMENT
– Ensure Adequate VentilationEnsure Adequate Ventilation
↑↑ FiO2FiO2
Ineffective with shuntingIneffective with shunting
Prolonged O2 > 40% causes O2 toxicityProlonged O2 > 40% causes O2 toxicity
Must use caution with CO2 retainersMust use caution with CO2 retainers
– Chronic hypercapnia causes CO2 retainersChronic hypercapnia causes CO2 retainers
to use hypoxic driveto use hypoxic drive
– Too much O2 can depress respirationsToo much O2 can depress respirations
145. Gastrointestinal BleedingGastrointestinal Bleeding
HematemesisHematemesis – vomiting of blood (or coffee ground– vomiting of blood (or coffee ground
material) (indicates bleeding above the duodenum )material) (indicates bleeding above the duodenum )
MelenaMelena – passage of black tarry stools > 50ml (indicates– passage of black tarry stools > 50ml (indicates
degradation of blood in the bowel)degradation of blood in the bowel)
HematocheziaHematochezia – passage of red blood (rectal bleeding)– passage of red blood (rectal bleeding)
Occult BleedingOccult Bleeding – bleeding that is not apparent to the– bleeding that is not apparent to the
patient and results from small amounts of bloodpatient and results from small amounts of blood
Obscure BleedingObscure Bleeding – occult or obvious but source not– occult or obvious but source not
identifiedidentified
146. Gastrointestinal BleedingGastrointestinal Bleeding
HematemesisHematemesis –– always UGI sourcealways UGI source
MelanaMelana –– indicates blood has been in GI tractindicates blood has been in GI tract
for extended periodsfor extended periods
– Mostly UGIMostly UGI
– Small bowelSmall bowel
– Rt colon (if bleeding relatively slow)Rt colon (if bleeding relatively slow)
HematocheziaHematochezia
– Mostly colonMostly colon
– Massive UGI bleeding (not enough time for degradation)Massive UGI bleeding (not enough time for degradation)
147.
TREATMENTTREATMENT
– Find the underlying causeFind the underlying cause
– Fluid volume replacementFluid volume replacement
– Endoscopy or colonoscopyEndoscopy or colonoscopy
– Medical and /or surgical therapyMedical and /or surgical therapy
SomatostatinSomatostatin
IV or intra-arterial vasopressinIV or intra-arterial vasopressin
SclerotherpaySclerotherpay
Angiography with embolizationAngiography with embolization
ElectrocoagulationElectrocoagulation
Band ligationBand ligation
Balloon tamponade (Sengstaken-Blackmore tube)Balloon tamponade (Sengstaken-Blackmore tube)
Gastrointestinal BleedingGastrointestinal Bleeding
148. The PancreasThe Pancreas
The Pancreas secretes digestive enzymes,The Pancreas secretes digestive enzymes,
bicarbonate, water, and some electrolytes intobicarbonate, water, and some electrolytes into
the duodenum via the pancreatic ductthe duodenum via the pancreatic duct
– Lipase, Amylase, TrypsinLipase, Amylase, Trypsin
The Pancreas also producesThe Pancreas also produces
and secretes insulinand secretes insulin
150. PancreatitisPancreatitis
PATHOSHYSIOLOGYPATHOSHYSIOLOGY
• Inactive pancreatic enzymes are activated outsideInactive pancreatic enzymes are activated outside
of the duodenumof the duodenum
• The swelling pancreas causes fluids to shift intoThe swelling pancreas causes fluids to shift into
the retro peritoneum and bowelthe retro peritoneum and bowel
• Fluid shifts can cause severe hypovolemia andFluid shifts can cause severe hypovolemia and
hypotensionhypotension
• Inflammation cause commotion around pancreasInflammation cause commotion around pancreas
151. PancreatitisPancreatitis
MANY CAUSESMANY CAUSES
– AlcoholismAlcoholism
– Biliary DiseaseBiliary Disease
– GallstonesGallstones
– InfectionsInfections
– HyperparathyroidismHyperparathyroidism
– HypertriglyceridemiaHypertriglyceridemia
– HypercalcemiaHypercalcemia
– Peptic Ulcer DiseasePeptic Ulcer Disease
– Cystic FibrosisCystic Fibrosis
– Vascular DiseaseVascular Disease
– Multiple DrugsMultiple Drugs
– Much Much MoreMuch Much More
156. PancreatitisPancreatitis
FULMINATING PANCREATITISFULMINATING PANCREATITIS
• Signs & SymptomsSigns & Symptoms
Tachycardia & low BP (may be the only sign)Tachycardia & low BP (may be the only sign)
Pulmonary & cerebral insufficiencyPulmonary & cerebral insufficiency
Acute diabetic ketosis or oliguriaAcute diabetic ketosis or oliguria
Hemorrhagic pancreatitis may appearHemorrhagic pancreatitis may appear
159. ReferencesReferences
American Heart Association. (2005). Guidelines 2005 for Cardiopulmonary
Resuscitation and Emergency Cardiovascular Care. Available at:
www.americanheart.org.
Bridges EJ.(2006) Pulmonary artery pressure monitoring: when, how, and what
else to use. AACN Adv Crit Care. 2006;17(3):286–303.
Chulay, M., Burns S. M. (2006). AACN Essentials of Critical Care Nursing.
McGraw-Hill Companies, Inc., Chapter 23.
Finkelmeier, B., Marolda, D. (2004) Aortic Dissection, Journal of Cardiovascular
Nursing: 15(4):15–24.
Hughes E. (2004). Understanding the care of patients with acute pancreatitis.
Nurs Standard: (18) pgs 45-54.
Sole, M. L., Klein, D. G. & Moseley, M. (2008). Introduction to Critical Care
Nursing. 5th ed. Philadelphia, Pa: Saunders.
Thelan, L. A., Urden, L. D., Lough, M. E. (2006). Critical care: Diagnosis and
Treatment for repair of abdominal aortic aneurysm. St. Louis, Mo.:
Mosby/Elsevier. pg 145-188.
160. References ContinuedReferences Continued
Urden, L., Lough, M. E. & Stacy, K. L. (2009). Thelan's Critical Care Nursing:
Diagnosis and Management (6th ed). St. Louis, Mo.: Mosby/Elsevier.
Woods, S., Sivarajan Froelicher, E. S., & Motzer, S. U. (2004). Cardiac Nursing.
5th ed. Philadelphia, Pa: Lippincott Williams & Wilkins.
Wynne J, Braunwald E. (2004). The Cardiomyopathies in Braunwald's Heart
Disease: A Textbook of Cardiovascular Medicine (7th Edition). Philadelphia:
W.B. Saunders, vol. 2, pps. 1659–1696, 1751–1803.
Zimmerman & Sole. (2001). Critical Care Nursing (3rd Edition). WB Saunders.,
pgs. 41-80, 176-180, 242-266.
Anderson, L. (July 2001). Abdominal Aortic Aneurysm, Journal of
Cardiovascular Nursing:15(4):1–14, July 2001.
Irwin, R. S.; Rippe, J. M. (January 2003). Intensive Care Medicine. Lippincott
Williams & Wilkins, Philadelphia: pgs. 35-548.
Wung, S., Aouizerat, B. E. (Nov/Dec 2004). Aortic Aneurysms. Journal of
Cardiovascular Nursing. Lippincott Williams & Wilkins, Inc.:19(6):409-416, 34(2).
Notes de l'éditeur
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002 As plaque develops and the coronary arteries become increasingly narrower, collateral branches form to help supply those areas of heart muscle. MI’s with no collateral circulation tend to suffer more severe infarctions and more hemodynamic compromise. Edema and color changes (within the heart) are evident 6 hours after an MI. LV function is altered immediately in ischemic states as well as in infarctions. Wall thickness decreases 8 to 10 days later due to a natural physiological cleanup and/or necrotic tissue removal. Scar tissue and tissue remodeling occur later and may lead to cardiac failure. Transmural MI involves full thickness of the myocardium whereas subendocardial MI (non-Q wave) involves partial thickness.
COMMON CRITICAL CONDITIONS Part One July 2004November 2002 Cardiac Enzymes: Troponin The troponin level rises within 4-6 hours after an AMI, peaks in 24 hours, and returns to baseline within 7-10 days. CK or CPK MB-CK is the cardiac specific isoenzyme MB-CK is normally less then 5% of the CK The CK level rises within 4-8 hours, peaks in 8-58 hours (with an average of 24 hours), and returns to baseline within 3-4 days. LDH LDH 1 is the cardiac specific isoenzyme When LDH 1 > LDH 2 , an AMI is probably occurring The LDH level rises within 24-48 hours, peaks within 3-6 days, and returns to baseline within 8-14 days. False positives enzyme levels may be seen in conditions that involve muscle injury (trauma, disease, vigorous exercise or rhabdomyolysis)
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002 Coronary Circulation: RCA Supplies the SA node, AV node, bundle of his, posterior papillary muscles, inferior wall of the left ventricle, and the posterior third of the septum The RCA supplies most of the blood supply to the inferior wall of the left ventricle for most people A person is said to be right dominant when the RCA supplies most of the blood supply to the inferior wall (of the left ventricle) IWMI usually due to RCA occlusion Watch for problems associated with the SA node (tachycardia, bradycardia, sick sinus or sinus arrest), the AV node (AV blocks), the right ventricle (RV involvement), and the posterior papillary muscles (MR or papillary muscle rupture). LAD (branches off left main artery) Supplies the anterior wall of the left ventricle, some of the lateral wall, and most of the intra-ventricular septum (including it’s conduction system) AWMI usually due to LAD occlusion Watch for problems involving large areas of the anterior left ventricle (cardiogenic shock) and problems involving the septum (blocks and VSD). Circumflex (branches off left main artery) Supplies the lateral and posterior walls of the left ventricle A small percentage of people have a short RCA and the circumflex artery then wraps around and supplies most of the inferior wall A person is said to be left dominant when the circumflex artery supplies most of the blood supply to the inferior wall (of the left ventricle) Lateral and/or posterior wall MI usually due to circumflex occlusion
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002 Two or more leads of a group: IWMI Leads II, III and aVF view the inferior wall (of the left ventricle) Reciprocal changes are seen in leads I, and aVL AWMI Leads V 1 -V 4 view the anterior-septal wall (left ventricle) Reciprocal changes are seen in leads II, III, and AVF Lateral wall MI Leads I, aVL, V 5 and V 6 view the lateral wall (left ventricle) Reciprocal changes are seen in leads II, III, and aVF Posterior wall MI Posterior MI’s are difficult to detect on a 12 lead EKG because no leads are placed directly over the posterior Changes are reflected on the opposite walls (Instead of ST elevations, you will see ST depression. Instead of Q waves, you will see tall R waves. Instead of T wave inversions, you will see upright T waves) Reciprocal changes may be seen in leads V 1 and V 2 Right Ventricle Leads V 3 R – V 6 R view the RV
COMMON CRITICAL CONDITIONS Part One July 2004November 2002 Two or more leads of a group: IWMI Leads II, III and aVF view the inferior wall (of the left ventricle) Reciprocal changes are seen in leads I, and aVL AWMI Leads V 1 -V 4 view the anterior-septal wall (left ventricle) Reciprocal changes are seen in leads II, III, and AVF Lateral wall MI Leads I, aVL, V 5 and V 6 view the lateral wall (left ventricle) Reciprocal changes are seen in leads II, III, and aVF Posterior wall MI Posterior MI’s are difficult to detect on a 12 lead EKG because no leads are placed directly over the posterior Changes are reflected on the opposite walls (Instead of ST elevations, you will see ST depression. Instead of Q waves, you will see tall R waves. Instead of T wave inversions, you will see upright T waves) Reciprocal changes may be seen in leads V 1 and V 2 Right Ventricle Leads V 6 R - V 3 R view the RV
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002 NTG Dilates coronary arteries Decreases preload (decreases, afterload some) MSO 4 Morphine is the analgesic of choice with AMI because it also reduces preload and decreases myocardial oxygen demand. Morphine decreases anxiety, restlessness, and autonomic nervous system activity. Aspirin Inhibits platelet aggregation Heparin Prevents further extension of existing thrombi and/or new clot formation (blocks conversion of prothrombin to thrombin and fibrinogen to fibrin) Beta Blockers Slow heart rate and lower BP Encourages electrical stability Improves mortality ACE Inhibitors Reduce afterload (vasodilatation) Reduces work of heart Decreases remolding effects GP IIb IIIa Inhibitors (anti-thrombolytics) Integrilin Reopro Thrombolytics Given up to 12 hours from the onset of an AMI Contraindicated in patients with active bleeding, BP>200/120, major surgery within 2 weeks, CPR >10 min, recent head trauma, suspected aortic dissection, pregnancy, CVA within 1 year, history of a hemorrhagic CVA, of major illnesses or cancers Anti-Lipidemics HDH is associated with risk LDH is associated with risk Look at the HDL : LDL ratio
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002 Increased incidence of sudden death or blood clots EDV) = the volume of blood in each ventricle at the end of diastole, usually about 120–130 mL but sometimes reaching 200–250 mL in the normal heart.
COMMON CRITICAL CONDITIONS Part One July 2004November 2002 Increased incidence of sudden death or blood clots
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002 Generalized Treatment of Cardiomyopathy: Treat Symptoms Monitor For Signs of Worsening Heart Failure Daily Weights Prone To Digoxin Toxicity Due To Renal Perfusion Monitor Digoxin Levels Give Positive Inotropic Drugs (Except With Hypertropic Cardiomyopathy) Give Vasodilators (Except With Hypertropic Cardiomyopathy) Reduce Preload & Afterload Diuretics Calcium Channel Blockers As Indicated Beta Blockers As Indicated IABP Vasodilators As Indicated Fluid Restriction Give O2 With Exacerbations & As Needed Give Antidysrhythmic Agents As Needed Restrict Sodium Decrease Activity, Plan Activities & Rest Consider Heart Transplant Educate Patient & Family Give Emotional Support
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002 AFib TREATMENT O2 and monitor. Slow rate when necessary. ECG Attempt to convert with medications if relatively new rhythm and hemodynamically stable. Prepare for synchronized cardioversion if hemodynamically unstable. Chronic atrial fibrillation usually treated with coumadin, ASA, etc.
COMMON CRITICAL CONDITIONS Part One July 2004November 2002 AFL TREATMENT O2 and monitor. ECG Attempt to convert with medications if relatively new rhythm and hemodynamically stable (beta-blockers, calcium channel blockers, digoxin). Prepare for synchronized cardioversion if hemodynamically unstable.
COMMON CRITICAL CONDITIONS Part One July 2004November 2002 WAP TREATMENT O2 and monitor ECG
COMMON CRITICAL CONDITIONS Part One July 2004November 2002 Atrial or Supraventricular tachycardia (SVT) is a fast heart rate that starts in the upper chambers of the heart. Some forms are called paroxysmal atrial tachycardia (PAT) or paroxysmal supraventricular tachycardia (PSVT). SVT TREATMENT O2 and monitor. ECG May attempt vagal maneuvers. May require beta-blockers, calcium channel blockers, etc. Prepare for synchronized cardioversion if hemodynamically unstable.
COMMON CRITICAL CONDITIONS Part One July 2004November 2002 VT TREATMENT Immediate defibrillation or cardioversion. CPR and ACLS
COMMON CRITICAL CONDITIONS Part One July 2004November 2002 Torsades TREATMENT MgSO4 Immediate defibrillation. CPR and ACLS.
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002 Pulmonary (LVF) and/or systemic (RVF) congestion is present. The weakened LV doesn’t empty properly and backs up toward the pulmonary vasculature. The increased pressures allow fluid to leak back into the pulmonary interstitial spaces and into the alveolus. Back pressure form the RV to the systemic venous system leads to increased venous pressures with engorgement of the liver and spleen and third-spacing of fluid into interstitial spaces, causing peripheral edema and ascites.
COMMON CRITICAL CONDITIONS Part One July 2004November 2002 Cardiogenic Pulmonary Edema = Elevated PAP, Elevated PAWP Non-cardiogenic Pulmonary Edema = Elevated PAP, Normal PAWP
COMMON CRITICAL CONDITIONS Part One July 2004November 2002 When blood volume is low, juxtaglomerular cells in the kidneys secrete renin directly into circulation. Plasma renin then carries out the conversion of angiotensinogen released by the liver to angiotensin I. Angiotensin I is subsequently converted to angiotensin II by the enzyme angiotensin converting enzyme found in the lungs.
COMMON CRITICAL CONDITIONS Part One July 2004November 2002 Class I: Patient with cardiac disease without resulting limitation of physical activity. Ordinary physical activity does not cause undue fatigue, palpitations, dyspnea or angina. Class II: Patient with cardiac disease resulting in slight limitation of physical activity. They are comfortable at rest but ordinary physical activity results in fatigue, palpitations, dyspnea or angina. Class III: Patient with cardiac disease resulting in marked limitations of physical activity. They are comfortable at rest but, less than ordinary activity causes fatigue, palpitations, dyspnea or angina. Class IV: Patient with cardiac disease resulting in inability to do any physical activity without discomfort. Symptoms of cardiac insufficiency or angina are increased when any activity is attempted.
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002 OPTIMIZE CARDIAC OUTPUT Improve Oxygenation O 2 Intubation PEEP Diuretics Decrease Myocardial Oxygen Consumption Bedrest (HOB elevated) Physical comfort (temperature control) Emotional control (keep informed, sedative prn) Gradually increase activity as tolerated, rest between activities Decrease Preload Diuretics (usually loop diuretics such as furosemide) High fowler’s position (legs dependent) Venous vasodilator (NTG, MSO 4 ) Sodium and fluid restriction Increase Contractility Cardiac glycosides (digoxin) Positive Inotropics (dopamine, dobutamine) Decrease Afterload Ace Inhibitors (captopril, enalapril) Nitroprusside (if hypertensive) Calcium channel blockers Dobutamine, Primacor Pulmonary vasodilators (aminophylline) IABP Prevent Valsalva Maneuvers Stool softeners Exhaling when turning Manage Dysrhythmias Atrial: Digoxin may be used to decrease ventricular rate by increasing refractoriness of the AV node. Ventricular: Lidocaine or amiodarone if necessary (procainamide and bretlium may significantly decrease contractility) Beta Blockers Used for mild CHF Protects heart form excessive catecholamines Cor Pulmonale (RVF) O 2 Therapy Pulmonary Vasodilators RVF Due to Pulmonary Embolus O 2 Therapy Anticoagulants Thrombolytics (if significant RVF or hypoxia)
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002 Hypovolemic Shock Inadequate perfusion to the tissues due to insufficient intravascular volume. Cardiogenic Shock Inadequate perfusion to the tissues due to heart failure. Distributive Shock (Anaphylactic, Septic, and Spinal Shock) Inadequate perfusion to the tissues due to maldistribution of blood flow out of the intravascular space causing insufficient intravascular volume. Obstructive Shock Inadequate perfusion to the tissues due to obstruction of blood flow. Causes: Pulmonary Embolus Tamponade Tension Pneumothorax Aortic Aneurysm
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002 Orthostatic Hypotension
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002 Self destructive form of shock High mortality rate (75-100%) Occurs in 10% of AMI’s Usually means loss of at least 40% LV function Ventricular gallop = S3
COMMON CRITICAL CONDITIONS Part One July 2004November 2002 Optimize Cardiac Output
COMMON CRITICAL CONDITIONS Part One July 2004November 2002 Histamines cause massive vasodilatation
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002 Causes of Obstructive Shock: Pulmonary Embolus Tamponade Tension Pneumothorax Aortic Aneurysm
COMMON CRITICAL CONDITIONS Part One July 2004November 2002 Cardiac Tamponade & Beck’s Triad: 1. Low BP 2. Distended Neck Veins 3. Muffled Heart Sounds May have Narrowed Pulse
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002 MODS = Multiple Organ Dysfunction Syndrome
COMMON CRITICAL CONDITIONS Part One July 2004November 2002 Definitions – ACCP/SCCM Consensus Conference Definition Bone et al.1992. Chest 101:1644-1655. Sepsis: a systemic inflammatory response to infection Severe Sepsis: systemic inflammation, coagulation and impaired fibinolysis. Septic Shock: severe sepsis defined as sepsis-induced hypotension (systolic blood pressure < 90mmHg or a reduction of=40mmHg from baseline in the absence of other causes for hypotension) despite adequate fluid resuscitation along with the presence of perfusion abnormalities. Patients receiving inotropic or vasopressor agents may no longer be hypotensive by the time that they manifest hypoperfusion abnormalities or organ dysfunction, yet they would be considered having septic shock.
COMMON CRITICAL CONDITIONS Part One July 2004November 2002 Toxins and bradykinins cause massive vasodilatation, a positive inotropic effect and stimulate the respiratory rate. May cause release of myocardial depressant factor in late phase. May stimulate the clotting cascade. Often leads to ARDS or/and DIC.
COMMON CRITICAL CONDITIONS Part One July 2004November 2002 Optimize intravascular volume Consider Xygris (Activated Protein C)
Definition: Measuring and monitoring the factors that influence the force and flow of blood. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
The Fick Principle : Calculates consumption of O2 over time NIC0 : Partial CO2 rebreathing (NICO) Thermodilution : PA Catheter TEBCO : Electrical impedance of the thorax (TEB) NICCO : ECHO : Uses doppler ultrasound MUGA Scan : Nuclear heart scan SVV : CCO, SVV / SV, SVR COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
1) Normal Values: CVP = 1-7 mmHg PAWP = 6-12 mmHg CO = 4.0-8.0 L/Min. CI = 2.5-4.0 L/Min. SVR = 700=1500 dynes/sec/cm 5 PVR = 100-250 dynes/sec/cm 5 RVSW = 10-15 gm 2 /beat LVSW = 60-80 gm 2 /beat COMMON CRITICAL CONDITIONS Part One July 2004November 2002
1) Normal Values: CVP = 1-7 mmHg PAWP = 6-12 mmHg CO = 4.0-8.0 L/Min. CI = 2.5-4.0 L/Min. SVR = 700=1500 dynes/sec/cm 5 PVR = 100-250 dynes/sec/cm 5 RVSW = 10-15 gm 2 /beat LVSW = 60-80 gm 2 /beat COMMON CRITICAL CONDITIONS Part One July 2004November 2002
Normal SvO2 = 75% COMMON CRITICAL CONDITIONS Part One July 2004November 2002
SVV: Arterial pulse pressure falls during inspiration and rises during expiration due to changes in intra-thoracic pressure secondary to negative pressure ventilation. Variations over 10mmHg have been referred to as pulsus paradoxus. Pulsus Paradoxus is the origin of SVV value. Occurs with spontaneously breathing patients. Reverse Pulsus Paradoxus occurs during positive pressure ventilation. COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002 Looks like a CVP waveform, but the timing is different
COMMON CRITICAL CONDITIONS Part One July 2004November 2002 Looks like a CVP waveform – just occurs later
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002 May do carotid ultrasound.
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002 Type I often preceded Type II.
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002 In COPD, bronchospasm, mucus plugs, inflammation and airway obstruction in general worsen ventilation disrupting the balance between ventilation and perfusion.
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002 Somatostatin is classified as an inhibitory hormone, whose main actions are to: Inhibit the release of growth hormone (GH) Inhibit the release of thyroid-stimulating hormone (TSH) Suppress the release of gastrointestinal hormones Gastrin Cholecystokinin (CCK) Secretin Motilin Vasoactive intestinal peptide (VIP) Gastric inhibitory polypeptide (GIP) Enteroglucagon (GIP) Lowers the rate of gastric emptying, and reduces smooth muscle contractions and blood flow within the intestine. Suppress the release of pancreatic hormones Inhibit the release of insulin Inhibit the release of glucagon Suppress the exocrine secretory action of pancreas. Somatostatin opposes the effects of Growth Hormone-Releasing Hormone (GHRH)
COMMON CRITICAL CONDITIONS Part One July 2004November 2002 Sphincter or Oddi
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002
COMMON CRITICAL CONDITIONS Part One July 2004November 2002